Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Pre-menstrual Syndrome Treatment Market Portraiture
2.2 Global Pre-menstrual Syndrome Treatment Market Share, by Drug type, 2015 (US$ Mn)
2.3 Global Pre-menstrual Syndrome Treatment Market, by Geography, 2015 (Value %)
Chapter 3 Global Pre-menstrual Syndrome Treatment Market Analysis
3.1 Global Pre-menstrual Syndrome Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Growing Awareness about PMS has Attracted the Demand for PMS Management Drugs
3.2.2 Challenges
3.2.2.1 Lack of Social Appreciation and Attachment of Stigma
3.2.3 Opportunities
3.2.3.1 Proliferation of Basic Healthcare Campaigns and Initiatives
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Pre-menstrual Syndrome Treatment Market
Chapter 4 Global Pre-menstrual Syndrome Treatment Market Analysis, by Drugs Type, 2014-2024 (US$ Mn)
4.1 Introduction
4.2 Analgesics (pain killers)
4.3 Oral Contraceptive Pills (OCPs)
4.4 Gonadotropin-releasing Hormone (GnRH)
4.5 Antidepressants
4.6 Ovarian Suppressors
4.7 Diuretics
4.8 Benzodiazepines
Chapter 5 Global Pre-menstrual Syndrome Treatment Market, By Geography, 2014-2024 (US$ Mn)
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa (UAE, Saudi Arabia, South Africa)
Chapter 6 Company Profiles
6.1 Alva-Amco Pharmacal Cos., Inc.
6.2 Bayer, Inc.
6.3 Chattem, Inc. (Sanofi)
6.4 DEKK-TEC, Inc.
6.5 G. R. Lane Health Products Ltd
6.6 McNeil Consumer Healthcare
6.7 MetP Pharma AG
6.8 Pherin Pharmaceuticals, Inc.
6.9 Umecrine Mood AB
6.10 Umecrine Mood AB
6.11 Novartis AG
6.12 GlaxoSmithKline Plc
List of Figures
FIG. 1 Global Pre-menstrual Syndrome Treatment Market: Research Methodology
FIG. 2 Global Pre-menstrual Syndrome Treatment Market Share, by Drug type, 2015 (US$ Mn)
FIG. 3 Global Pre-menstrual Syndrome Treatment Market, by Geography, 2015 (Value %)
FIG. 4 Attractive Investment Proposition: Global Pre-menstrual Syndrome Treatment Market, by Geography
FIG. 5 Competitive Analysis: Key Players in Global Pre-menstrual Syndrome Treatment Market
FIG. 6 Pre-menstrual Syndrome Treatment Analgesics (pain killers) Market, 2014 – 2024 (US$ Mn)
FIG. 7 Pre-menstrual Syndrome Treatment Oral Contraceptive Pills (OCPs) Market, 2014 – 2024 (US$ Mn)
FIG. 8 Pre-menstrual Syndrome Treatment Gonadotropin-releasing Hormone (GnRH) Market, 2014 – 2024 (US$ Mn)
FIG. 9 Pre-menstrual Syndrome Treatment Antidepressants Market, 2014 – 2024 (US$ Mn)
FIG. 10 Pre-menstrual Syndrome Treatment Ovarian Suppressors Market, 2014 – 2024 (US$ Mn)
FIG. 11 Pre-menstrual Syndrome Treatment Diuretics Market, 2014 – 2024 (US$ Mn)
FIG. 12 Pre-menstrual Syndrome Treatment Benzodiazepines Market, 2014 – 2024 (US$ Mn)
List of Tables
TABLE 1 Global Pre-menstrual Syndrome Treatment Market, 2014-2024 (US$ Mn)
TABLE 2 Global Pre-menstrual Syndrome Treatment Market, by Geography, 2014 – 2024 (US$ Mn)
TABLE 3 North America Pre-menstrual Syndrome Treatment Market, by Country, 2014 – 2024 (US$ Mn)
TABLE 4 Europe Pre-menstrual Syndrome Treatment Market, by Country, 2014 – 2024 (US$ Mn)
TABLE 5 Asia-Pacific Pre-menstrual Syndrome Treatment Market, by Country, 2014 – 2024 (US$ Mn)
TABLE 6 Latin America Pre-menstrual Syndrome Treatment Market, by Country, 2014 – 2024 (US$ Mn)
TABLE 7 Middle East and Africa Pre-menstrual Syndrome Treatment Market, by Country, 2014 – 2024 (US$ Mn)
TABLE 8 Alva-Amco Pharmacal Cos., Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 9 Bayer, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 10 Chattem, Inc. (Sanofi): Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 11 DEKK-TEC, Inc.: Company Snapshot (Business Description; Financial Performance; Product Position Portfolio; News Coverage)
TABLE 12 G. R. Lane Health Products Ltd: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 13 McNeil Consumer Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 14 MetP Pharma AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 Pherin Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 16 Umecrine Mood AB: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 17 Umecrine Mood AB: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 18 Novartis AG: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
TABLE 19 GlaxoSmithKline Plc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)